Safic-Alcan Announces New Distribution Partnership with Pharmaffiliates for Europe and North Africa

Safic-Alcan Announces New Distribution Partnership with Pharmaffiliates for Europe and North Africa

Paris, La Défense, April 1st 2024 - Safic-Alcan, a global distributor of specialty chemicals and ingredients, is pleased to announce a strategic partnership with Pharmaffiliates, a leading research-based organization specializing in the synthesis and supply of reference standards, certified reference materials, pharmaceutical & non pharmaceutical standards, and CRAMS.

As part of this collaboration, Safic-Alcan will serve as the exclusive distributor of Pharmaffiliates’ products in all European countries, excluding Portugal and Greece. Additionally, Safic-Alcan will extend its distribution network to encompass Algeria, Morocco, and Tunisia. 

This partnership represents a significant milestone for both Safic-Alcan and Pharmaffiliates, leveraging Safic-Alcan's extensive distribution network for Pharmaceutical produtcs and Pharmaffiliates' high-quality products and expertise. Through this collaboration, customers across Europe and North Africa will benefit from enhanced access to Pharmaffiliates’ extensive portfolio of reference standards and research chemicals.

Pharmaffiliates, headquartered in Panchkula in India, has established itself as a trusted supplier in the pharmaceutical industry, offering a wide range of products including reference standards, impurities, metabolites, APIs, and more. With state-of-the-art facilities and a team of experienced professionals, Pharmaffiliates is committed to delivering products of the highest quality and purity to support pharmaceutical research and development efforts worldwide.

Commenting on the partnership, Gael Garnaud, Pharmaceuticals Business Development Director at Safic-Alcan, expressed excitement about the collaboration, stating, "We are delighted to offer our pharmaceutical customers in Europe a wide range of reference substances for compounds listed in the monographs of the European Pharmacopoeia."

Arianna Fusco, Pharmacist and Product Manager for Pharmaffiliates at Safic Alcan adds,  

This partnership offers a very interesting complementary product. Our customers are offered support in the supply of API and now reference substances. Each of these is accompanied by a full certificate of analysis, to help achieve accurate analysis results.

Similarly, Abhinav sabharwal, Vice President at Pharmaffiliates, emphasized the strategic significance of the partnership, saying, "Safic-Alcan's reputation for excellence and extensive distribution network make them the ideal partner to expand our reach in Europe and North Africa. We are confident that this collaboration will enable us to better serve our customers and drive mutual growth." 

About Pharmaffiliates

Pharmaffiliates is a contract research and development organization involved in the synthesis and supply of pharmaceutical and non-pharmaceutical standards, analytical services and has expertise in CRAMS. With a focus on quality, reliability, and customer satisfaction, Pharmaffiliates is a trusted partner for pharmaceutical research and development, providing high-quality products and services to customers globally.

About Safic-Alcan

Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals, and nutraceuticals industries. With a network of 35 offices strategically located in Europe, Turkey, Middle East, North America, Mexico, South America, China and South Africa, and 780 people worldwide, Safic-Alcan generated a turnover of 907 M€ in 2022. Learn More

Popular post